NHS to Offer Drug for Tuberous Sclerosis Complex

by Kathy Jones on  September 27, 2011 at 7:34 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

British children suffering from a rare form of genetic disorder now have an alternative to surgery after the NHS revealed that it will be offering a new drug that promises to reduce the tumor size that occurs in this condition by more than 50 percent.
 NHS to Offer Drug for Tuberous Sclerosis Complex
NHS to Offer Drug for Tuberous Sclerosis Complex

Known as tuberous sclerosis complex (TSC), the condition affects more than 1,600 children in UK and is responsible for the growth of non-malignant tumors in brain and kidneys. Until now, the only form of treatment has been surgery.

However the new drug, known as everolimus, has been found to shrink the subependymal giant cell astrocytoma (SEGA) tumors associated with TSC by more than 50 percent. NHS doctors can now apply for funding from the health trusts after the drug was granted orphan drug status for rare diseases.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity Tuberous Sclerosis 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...